NCT05381285

Brief Summary

Study Title Predictive Model of Mortality and Major Morbidity in Preterm Neonates in the Perinatal Period Internal ref. no. / short title Survival Model Study Design Observational Population-based Cohort Study Planned Sample Size Retrospective analysis of Database Planned Study Duration 6-months Primary Objectives To derive a mathematical model for predicting mortality and the composite of mortality/major-morbidity before and immediately after birth in preterm infants Secondary Objectives Statistical Methodology and Analysis Mixed-model multivariable logistic regression analysis

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 1, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 19, 2022

Completed
2 years until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

August 31, 2023

Status Verified

August 1, 2023

Enrollment Period

6 months

First QC Date

April 1, 2022

Last Update Submit

August 30, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Mortality

    In-hospital mortality

    40-weeks

  • Mortality or major morbidity

    In-hospital outcomes

    40-weeks

Interventions

Non-interventional study

Eligibility Criteria

Age0 Weeks - 16 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The whole population of preterm infants born before 34 weeks of gestation for 8 years (2011-2018) in Wales will be included in the retrospective cohort.

You may qualify if:

  • Preterm infants born alive at or less than 34 weeks of gestation.
  • Born in Welsh maternity and admitted for care to a Welsh neonatal unit.
  • Mother normally resident in Wales

You may not qualify if:

  • The mother is normally resident in England (detailed maternal data not available)
  • Congenital anomaly noted at birth (alters the natural probability of outcomes)
  • Duplicate episodes for an individual infant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Wales

Cardiff, CF14 4XW, United Kingdom

Location

Central Study Contacts

Mallinath Chakraborty, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2022

First Posted

May 19, 2022

Study Start

June 1, 2024

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

August 31, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations